Also, it evaluated the association between serum betatrophin levels and these microRNAs and their correlations with different metabolic and anthropometric parameters to support or exclude the therapeutic benefit of these microRNAs and betatrophin or their antagonists in the management of children with obesity and/or T2DM. The gene discussed is ANGPTL8; the disease is obesity disorder.